Loading...

ABEO ABEONA THERAPEUTICS INC Company Mergers 8-K Filing

BN T

B

ABEONA THERAPEUTICS INC

(ABEO)

2025 8-K

Show Summary

Summary

Asset Acquisitions

Asset Acquisitions

New Product Launches

Financial Results

Share Increase Approval

Q3 2024 Results

FDA Application Resubmission

Board Appointments

Q2 2024 Results

Amendment of Bylaws

Financial Results

Financial Update

Equity Incentive Plan Approval

Financial Results Press Rel...

FDA Accepts and Grants Prio...

Earnings Report

Change in Accounting Firm

Earnings Reports

Rights Offerings

Annual Meeting of Stockholders

Earnings Report

Board Restructuring

Earnings Report

Regulation FD Disclosure

External Links:

On May 9, 2025, Abeona Therapeutics Inc. agreed to sell a Priority Review Voucher to a buyer for $155 million, which they received approval for from the FDA on April 28, 2025. The sale is subject to customary closing conditions.

AI Assistant

ABEONA THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.